Back to Trades
Sweetnam Paul
CHIEF SCIENTIFIC OFFICERCIK 0002156367
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Sweetnam Paul, CHIEF SCIENTIFIC OFFICER, accounts for 2 disclosed filings worth $0, all concentrated in Retension Pharmaceuticals, Inc. (RTSN), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Oct 13 | RTSN Retension Pharmaceuticals, Inc. | Sweetnam Paul | CHIEF SCIENTIFIC OFFICER | Conversion | $0 |
| Oct 8 | RTSN Retension Pharmaceuticals, Inc. | Sweetnam Paul | Chief Scientific Officer | Other | $0 |
2 filings